Piper Jaffray Downgrades Endo Pharmaceuticals Holdings Inc (ENDP) to Neutral
Tweet
Share
E-mailGet Alerts ENDP Hot Sheet
Price: $0.29 --0%
Rating Summary:
14 Buy, 15 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Rating Summary:
14 Buy, 15 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Join SI Premium – FREE
Piper Jaffray downgraded Endo Pharmaceuticals Holdings Inc (NASDAQ: ENDP) from Overweight to Neutral with a price target of $28.00 (from $37.00).
For an analyst ratings summary and ratings history on Endo Pharmaceuticals Holdings Inc click here. For more ratings news on Endo Pharmaceuticals Holdings Inc click here.
Shares of Endo Pharmaceuticals Holdings Inc closed at $26.25 yesterday.
For an analyst ratings summary and ratings history on Endo Pharmaceuticals Holdings Inc click here. For more ratings news on Endo Pharmaceuticals Holdings Inc click here.
Shares of Endo Pharmaceuticals Holdings Inc closed at $26.25 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Downgrades Feng Tay Enterprises (9910:TT) to Hold
- Alpine Income Property Trust (PINE) PT Lowered to $18 at Jones Trading
- Uber Inc. (UBER) PT Raised to $96 at Tigress Financial Partners
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
